Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Allergic Encephalomyelitis

angiotensin ii, des-phe(8)- has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amundson, E; Kashani, N; Kelland, EE; Lee, S; Levy, AM; Lund, BT; Rodgers, KE; Stone, R	1

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and Allergic Encephalomyelitis

Article	Year
Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis. Neurobiology of disease, 2019, Volume: 127 Topics: Angiotensin I; Animals; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Neuroprotection; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Severity of Illness Index; Treatment Outcome	2019

Article

Year

Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis.

Neurobiology of disease, 2019, Volume: 127

Topics: Angiotensin I; Animals; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Neuroprotection; Neuroprotective Agents; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Severity of Illness Index; Treatment Outcome

2019